Cargando…

Hif-2α regulates lipid metabolism in alcoholic fatty liver disease through mitophagy

BACKGROUND: Disordered lipid metabolism plays an essential role in both the initiation and progression of alcoholic fatty liver disease (AFLD), and fatty acid β-oxidation is increasingly considered as a crucial factor for controlling lipid metabolism. Hif-2α is a member of the Hif family of nuclear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Mei-fei, Zhang, Guo-dong, Liu, Tong-tong, Shen, Jun-hao, Cheng, Jie-ling, Shen, Jie, Yang, Tian-yu, Huang, Cheng, Zhang, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730692/ https://www.ncbi.nlm.nih.gov/pubmed/36476627 http://dx.doi.org/10.1186/s13578-022-00889-1

Ejemplares similares

Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease
por: Zhang, Lijia, et al.
Publicado: (2022)

Cold exposure alters lipid metabolism of skeletal muscle through HIF-1α-induced mitophagy
por: Chen, Wentao, et al.
Publicado: (2023)

Stabilization of HIF-1α alleviates osteoarthritis via enhancing mitophagy
por: Hu, Sunli, et al.
Publicado: (2020)

HIF1α-dependent mitophagy facilitates cardiomyoblast differentiation
por: Zhao, Jin-Feng, et al.
Publicado: (2020)

HIF1α or mitophagy: which drives cardiomyocyte differentiation?
por: Villarejo-Zori, Beatriz, et al.
Publicado: (2020)

Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism
por: Mao, Fei-Fei, et al.
Publicado: (2023)

Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production
por: Ma, Zhenhua, et al.
Publicado: (2017)

Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy
por: Zhou, Tao, et al.
Publicado: (2019)

HIF-1α-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury
por: Fu, Zong-Jie, et al.
Publicado: (2020)

HIF-1α-Induced Mitophagy Regulates the Regenerative Outcomes of Stem Cells in Fat Transplantation
por: Zhang, Kai, et al.
Publicado: (2023)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
por: Chao, Hsu-Wen, et al.
Publicado: (2019)

Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
por: Tian, Feng, et al.
Publicado: (2018)

Effect of saxagliptin on the expression of HIF-1α in the liver of diabetic rats with fatty liver
por: Zhao, Qian, et al.
Publicado: (2018)

Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma
por: Liu, Yan-Mei, et al.
Publicado: (2016)

Activation of HIF-1α C-terminal transactivation domain protects against hypoxia-induced kidney injury through hexokinase 2-mediated mitophagy
por: Li, Zuo-Lin, et al.
Publicado: (2023)

The Effect of Sitagliptin on Lipid Metabolism of Fatty Liver Mice and Related Mechanisms
por: Xu, Bilin, et al.
Publicado: (2017)

FUNDC1-mediated mitophagy and HIF1α activation drives pulmonary hypertension during hypoxia
por: Liu, Ruxia, et al.
Publicado: (2022)

HIF-1α Ameliorates Diabetic Neuropathic Pain via Parkin-Mediated Mitophagy in a Mouse Model
por: He, Jian, et al.
Publicado: (2022)

UCHL1 alleviates apoptosis in chondrocytes via upregulation of HIF-1α-mediated mitophagy
por: Yan, Qiqian, et al.
Publicado: (2023)

HIF-1α in myocardial ischemia-reperfusion injury
por: Zheng, Jie, et al.
Publicado: (2021)

Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease
por: Wang, Xingchun, et al.
Publicado: (2022)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis
por: Zhang, Wen, et al.
Publicado: (2015)

Hydrogen sulphide in liver glucose/lipid metabolism and non‐alcoholic fatty liver disease
por: Mateus, Inês, et al.
Publicado: (2021)

Acacetin Protects against Non-Alcoholic Fatty Liver Disease by Regulating Lipid Accumulation and Inflammation in Mice
por: Liou, Chian-Jiun, et al.
Publicado: (2022)

Lipid droplet dynamics in alcoholic fatty liver disease
por: Schulze, Ryan J., et al.
Publicado: (2019)

HIF-1α knockdown by miRNA decreases survivin expression and inhibits A549 cell growth in vitro and in vivo
por: LI, WEI, et al.
Publicado: (2013)

Panax notoginseng saponins mitigate cisplatin induced nephrotoxicity by inducing mitophagy via HIF-1α
por: Liang, Xueyan, et al.
Publicado: (2017)

Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease
por: Pang, Lijun, et al.
Publicado: (2018)

Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
por: Mato, José M, et al.
Publicado: (2019)

The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity
por: Hazer, İlhan, et al.
Publicado: (2020)

Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease
por: Shi, Dongmei, et al.
Publicado: (2019)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Worenine reverses the Warburg effect and inhibits colon cancer cell growth by negatively regulating HIF-1α
por: Ji, Lijiang, et al.
Publicado: (2021)

ROS-dependent HIF1α activation under forced lipid catabolism entails glycolysis and mitophagy as mediators of higher proliferation rate in cervical cancer cells
por: Castelli, Serena, et al.
Publicado: (2021)

Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells
por: Seo, Jieun, et al.
Publicado: (2020)

Long-term HIF-1α stabilization reduces respiration, promotes mitophagy, and results in retinal cell death
por: Nsiah, Nana Yaa, et al.
Publicado: (2023)

HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
por: Du, Weinan, et al.
Publicado: (2017)

Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease
por: Li, Wenjun, et al.
Publicado: (2011)

Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
por: Li, Ting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e2j4uiudbhtmbatnq6lvnd2b2p